Antiretroviral Therapy with a Twice-Daily Regimen Containing 400 Milligrams of Indinavir and 100 Milligrams of Ritonavir in Human Immunodeficiency Virus Type 1-Infected Women during Pregnancy
2008 ◽
Vol 52
(4)
◽
pp. 1542-1544
◽
Keyword(s):
Hiv Rna
◽
ABSTRACT We evaluated the safety and efficacy of a twice daily regimen containing 400 mg of indinavir and 100 mg of ritonavir in 32 human immunodeficiency virus (HIV)-infected women during pregnancy. The median indinavir trough concentration was 208 ng/ml during the third trimester. At delivery, 26 of 28 women on indinavir-ritonavir had HIV RNA levels of <200 copies/ml. No infant was HIV infected. These data are encouraging for the use of this combination for prevention of mother-to-child transmission of HIV.
2000 ◽
Vol 181
(2)
◽
pp. 746-749
◽
2017 ◽
Vol 65
(8)
◽
pp. 1335-1341
◽
1996 ◽
Vol 18
(2)
◽
pp. 149-157
◽
1995 ◽
Vol 69
(6)
◽
pp. 3778-3788
◽
1996 ◽
Vol 70
(7)
◽
pp. 4474-4483
◽
2001 ◽
Vol 56
(3)
◽
pp. 138-139
1996 ◽
Vol 15
(7)
◽
pp. 604-610
◽
2003 ◽
Vol 69
(4)
◽
pp. 447-449
◽